Our data confirm the role of NF-κB-mediated inflammation in the development of T2D, and demonstrate the efficacy of MnP in preventing the progression to disease by specifically improving liver pathology and hepatic insulin resistance in obesity. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.